Myriad Genetics Inc Sustainability Reports

Myriad Genetics, Inc. is a genetic testing and precision medicine company that develops and commercializes molecular diagnostic tests. These tests assist in determining disease risk, guiding treatment choices, and assessing disease progression across multiple medical specialties.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 52990044IHUOUMETT163

FIGI: BBG001S86FS9

12 reports from 2011 to 2025

• Myriad Genetics Inc 2025 Corporate Responsibility Report
• Myriad Genetics Inc 2025 Climate-Related Financial Risk Report
• Myriad Genetics Inc 2024 Form 10-K
• Myriad Genetics Inc 2023 Form 10-K
• Myriad Genetics Inc 2022 Annual Report